Table 3.
Expression of SLeA and NCL at the cell membrane (NCLmem) in GC according to clinicopathological variables.
| Clinicopathological Variables | SLeA Expression n (%) |
p*-Value | NCLmem n (%) |
p*-Value | NCLmem+SLeA n (%) |
p*-Value |
|---|---|---|---|---|---|---|
| Stage | ||||||
| I | 8 (44%) | 0.020 | 2 (100%) | 0.337 | 0 (0%) | 0.772 |
| II | 37 (62%) | 4 (33%) | 4 (33%) | |||
| III | 50 (57%) | 12 (48%) | 9 (36%) | |||
| IV | 29 (83%) | 3 (38%) | 3 (38%) | |||
| Tumor size/extension (T) | ||||||
| T1 | 6 (50%) | 0.633 | - | 0.716 | - | 0.927 |
| T2 | 11 (65%) | - | - | |||
| T3 | 68 (65%) | 11 (42%) | 9 (35%) | |||
| T4 | 36 (63%) | 10 (48%) | 7 (33%) | |||
| Lymph node metastasis (N) | ||||||
| N0 | 28 (57%) | 0.651 | 4 (40%) | 0.862 | 2 (20%) | 0.551 |
| N1 | 24 (60%) | 3 (38%) | 2 (25%) | |||
| N2 | 18 (56%) | 4 (57%) | 3 (43%) | |||
| N3 | 50 (67%) | 10 (48%) | 9 (43%) | |||
| Distant metastasis (M) | ||||||
| M0 | 84 (56%) | 0.005 | 18 (50%) | 0.522 | 13 (33%) | 0.941 |
| M1 | 29 (81%) | 3 (38%) | 3 (38%) | |||
| Lauren Classification | ||||||
| Intestinal subtype | 77 (62%) | 0.191 | 11 (48%) | 0.671 | 8 (35%) | 0.917 |
| Mixed | 10 (46%) | - | - | |||
| Diffuse | 35 (69%) | 10 (42%) | 8 (33%) | |||
| Borrmann Classification | ||||||
| Type I | 4 (44%) | 0.744 | 1 (100%) | 0.641 | 1 (100%) | 0.228 |
| Type II | 46 (61%) | 7 (39%) | 5 (28%) | |||
| Type III | 27 (64%) | 3 (43%) | 1 (14%) | |||
| Type IV | 35 (61%) | 9 (50%) | 9 (50%) | |||
*Chi-square test for a 95% confidence interval.